Scout | Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Effect of HIV and Substance Use Comorbidity on the Placenta and Maternal Outcomes (R01 Clinical Trial Optional)

This grant opportunity focuses on researching the effects of HIV and antiretroviral therapy (ART) on the placenta during pregnancy. Although ART helps prevent the transmission of HIV from mother to child, it is linked to negative outcomes like preterm birth and stillbirth. Understanding the impact of HIV and ART on the placenta is crucial, especially in pregnant individuals who also experience…

Source

Agency: National Institutes of Health

Sub-agency: National Institute on Drug Abuse

Program: SBIR

Dates

Opportunity Released: October 30, 2023

Open for Submission: October 30, 2023

Submission Deadline: November 15, 2024

Application Window Closes: November 15, 2024

Keywords

HIV

antiretroviral therapy

vertical transmission

placenta

preterm birth

stillbirth

maternal outcomes

fetal outcomes

substance use

pregnancy.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers